Alphabet Inc.'s research organization starts Baseline Sleep Apnea Study #2

Photo by Adi Goldstein

Verily Life Sciences LLC is continuing to work on Baseline Sleep Apnea Study #2 in the context of disease obstructive sleep apnea of adult.

This study seeks to understand patient diagnostic and treatment journey and positive airway pressure (PAP) therapy compliance for Verily Sleep Apnea (VSA) program/app users. Participants will enroll remotely and may undergo a home sleep test (HST). Upon confirmation of obstructive sleep apnea (OSA) and prescription of PAP therapy, the participant will begin using the VSA app to supplement PAP treatment. After 90 days of active participation, the participant will be given instructions for follow-up care, as indicated.

The clinical trial started on July 8, 2020.

This will be a single arm study of participants that are diagnosed with Obstructive Sleep Apnea (OSA) during the study. Upon confirmation of OSA and prescription of positive airway pressure (PAP) therapy, the participant will begin using the Verily Sleep Apnea (VSA) app to supplement PAP treatment.

Volunteers may be involved in the study according to the requirements described below:

  • ages 18 or older;
  • able to speak and read English;
  • legal United States Resident with a Government Issued ID;
  • participating in the Project Baseline Community Study;
  • demonstrates understanding of the study requirements and is able and willing to sign the informed consent form;
  • own a smartphone with a data plan and be the primary user of the smartphone; smartphone must use Android Lollipop (5.1+/ API 22+) or iOS 11.X+;
  • own a computer with a web camera;
  • consistent access to electricity and Wi-Fi for the duration of the study;
  • have a high risk of OSA as determined by screening questionnaire;
  • good candidate for PAP therapy, in the opinion of the managing clinician;
  • without significant limitation in ability to participate in the study, in the opinion of the investigator.

The study location is Verily Life Sciences LLC (South San Francisco, California, United States, 94080).

Verily Life Sciences, also known as Verily (formerly Google Life Sciences) is Alphabet Inc.'s research organization devoted to the study of life sciences.

This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT04599803

Clinical Research News

Upcoming Clinical Trials

3
Subscribe